Nakamura Y, Tsumura Y, Tonogai Y, Shibata T, Ito Y
Division of Food Chemistry, National Institute of Health Sciences, Osaka Branch, Japan.
Fundam Appl Toxicol. 1997 Jun;37(2):106-16. doi: 10.1006/faat.1997.2322.
Differences in behavior among the chlorides of seven rare earth elements (REEs)-yttrium (Y), cerium (Ce), and praseodymium (Pr) (light REEs); europium (Eu) and dysprosium (Dy) (medium REEs); ytterbium (Yb) and lutetium (Lu) (heavy REEs)-were investigated through intravenous administration of the REEs to rats. (1) Distributions of REEs and mineral concentrations in the organs on Day 1 were investigated at low and high doses (9-10 and 18-20 mg REE/kg, or 56-66 and 112-132 mumol REE/kg). More than 78% of the REEs administered was distributed into liver, bone, and spleen. High doses of Y, Eu, and Dy markedly increased the accumulation of REEs in spleen and lungs as well as the concentration of Ca in liver, spleen, and lungs. (2) The distribution patterns of REEs and changes in Ca concentrations in major organs over time were investigated by the administration of Pr, Eu, Dy, Yb (low dose), and Y (high dose). REEs disappeared from the blood within 1 day but were retained in the organs for a long time. The percentages of the doses of Y, Eu, Dy, and Yb found in the liver were highest at 8 hr to 2 days, then decreased gradually; hepatic Pr levels, however, remained high. Changes in Ca concentrations in liver, spleen, and lungs were in accordance with those of REEs. (3) Severe hepatotoxicity was observed after administration of Ce and Pr; fatty liver, jaundice, and elevated serum GOT and GPT levels were most prominent on Day 3. Therefore, we hypothesized that REE chlorides might be categorized into three groups according to their ionic radii (light REEs, Y and medium REEs, and heavy REEs) and from their behavior, i.e., distribution pattern, Ca-accumulating action, and hepatotoxicity.
通过向大鼠静脉注射七种稀土元素(REEs)的氯化物——钇(Y)、铈(Ce)和镨(Pr)(轻稀土元素);铕(Eu)和镝(Dy)(中稀土元素);镱(Yb)和镥(Lu)(重稀土元素),研究了它们行为上的差异。(1)在低剂量和高剂量(9 - 10毫克稀土元素/千克,或56 - 66微摩尔稀土元素/千克,以及18 - 20毫克稀土元素/千克,或112 - 132微摩尔稀土元素/千克)下,研究了第1天各器官中稀土元素的分布和矿物质浓度。超过78%的注射稀土元素分布在肝脏、骨骼和脾脏中。高剂量的Y、Eu和Dy显著增加了脾脏和肺部中稀土元素的积累,以及肝脏、脾脏和肺部中钙的浓度。(2)通过注射Pr、Eu、Dy、Yb(低剂量)和Y(高剂量),研究了主要器官中稀土元素的分布模式以及随时间钙浓度的变化。稀土元素在1天内从血液中消失,但在器官中长时间留存。在肝脏中发现的Y、Eu、Dy和Yb剂量百分比在8小时至2天最高,然后逐渐下降;然而,肝脏中的Pr水平仍然很高。肝脏、脾脏和肺部中钙浓度的变化与稀土元素的变化一致。(3)注射Ce和Pr后观察到严重的肝毒性;脂肪肝、黄疸以及血清谷草转氨酶和谷丙转氨酶水平升高在第3天最为明显。因此,我们假设稀土氯化物可能根据其离子半径(轻稀土元素、Y和中稀土元素以及重稀土元素)以及它们的行为,即分布模式、钙积累作用和肝毒性,分为三组。